ArticleCell death & disease2014

Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib.

A-C Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.